Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones
Endoscopic Sphincterotomy Plus Large-Balloon Dilatation (ESLBD) Versus Conventional Endoscopic Treatment for Removal of Large Common Bile Duct Stones : A Prospective Comparative Multi Center Randomized Study
1 other identifier
interventional
150
0 countries
N/A
Brief Summary
Bile duct stone extraction is impossible after endoscopic sphincterotomy (ES) alone in approximatively 10% of cases (mostly because of stones' size). Adjunction of a mechanical lithotripsy (ML) is well established to improve clearance of common bile duct (CBD) stones. Because of inconstant success, high cost, and length of procedure, an alternative method was proposed in 2003: endoscopic sphincterotomy plus large balloon dilatation (ESLBD). If the safety of ESLBD is accepted in all recent published studies, it remains controversial wether ESLBD is superior to conventional endoscopic treatment associating ES± ML for CBD stones. Procedure treatment and place of ESLBD in CBD stones therapeutic strategy is unclear. The purpose of this prospective comparative multi center randomized study is to evaluate the superiority or not of ESLBD on conventional treatment (ES±ML) for the treatment of large bile duct stone (≥13mm) after standard ES, and to propose a new CBD stones therapeutic strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jul 2010
Longer than P75 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 5, 2015
CompletedFirst Posted
Study publicly available on registry
October 30, 2015
CompletedOctober 30, 2015
October 1, 2015
4.7 years
October 5, 2015
October 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success of common bile duct clearance in one session of ERCP (endoscopic retrograde cholangiopancreatography)
1 month
Secondary Outcomes (10)
Number of patients with mild or severe BLEEDING (Morbidity) after ERCP
1 month
Number of patients with mild or severe ACUTE PANCREATITIS (Morbidity) after ERCP
1 month
Number of patients with PERFORATION (Morbidity of ERCP)
1 day
Number of patients with post ERCP INFECTION as angiocholitis, cholecystitis or urine infection, septicemia (Morbidity of ERCP)
1 month
GLOBAL MORBIDITY of ERCP (number of patients with bleeding and/or acute pancreatistis and/or perforation and/or infection)
1 month
- +5 more secondary outcomes
Study Arms (2)
ESLBD
ACTIVE COMPARATOREndoscopic Sphincterotomy plus Large Balloon Dilatation +/- lithotripsy 1. ERCP with deep cancellation of BDS 2. Endoscopic large sphincterotomy 3. Large Balloon Dilatation of Oddi Sphincter: with the HERCULES, Cook 12, 15, 18 or 20 mm of diameter (adapted to stone diameter) 4. Stone extraction with dormia basket or extraction balloon 5. Mechanical Lithotripsy if needed
CONV
ACTIVE COMPARATORConventional treatment associating Endoscopic Sphincterotomy +/- Mechanical Lithotripsy (ES+/-LM) 1. ERCP with deep cancellation of BDS 2. Endoscopic large sphincterotomy 3. Stone extraction with dormia basket or extraction balloon 4. Mechanical Lithotripsy if needed
Interventions
Common bile duct cannulation with a cannulation catheter
Large Balloon Dilatation : with the HERCULES, Cook 12, 15, 18 or 20 mm of diameter (adapted to stone diameter)
After dilatation, extraction of stones is done with dormia basket or extraction balloon and if not possible a mechanical lithotripsy is performed
Eligibility Criteria
You may qualify if:
- Patient with CBD stones with a smaller diameter ≥ 13mm on cholangiogram
You may not qualify if:
- Active or history of acute pancreatitis
- Presence of intrahepatic stones
- History of Billroth II or roux-en-Y reconstruction
- Coagulation disorder (partial thromboplastin time \> 42 seconds, prothrombin time (Quick value) \< 50% and platelet count of \<50 000/mm3)
- Current anticoagulation or clopidogrel treatment
- Pregnancy
- Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Karsenti D, Coron E, Vanbiervliet G, Privat J, Kull E, Bichard P, Perrot B, Quentin V, Duriez A, Cholet F, Subtil C, Duchmann JC, Lefort C, Hudziak H, Koch S, Granval P, Lecleire S, Charachon A, Barange K, Cesbron EM, De Widerspach A, Le Baleur Y, Barthet M, Poincloux L. Complete endoscopic sphincterotomy with vs. without large-balloon dilation for the removal of large bile duct stones: randomized multicenter study. Endoscopy. 2017 Oct;49(10):968-976. doi: 10.1055/s-0043-114411. Epub 2017 Jul 28.
PMID: 28753698DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David KARSENTI, MD
Société Française d'Endoscopie Digestive
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 5, 2015
First Posted
October 30, 2015
Study Start
July 1, 2010
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
October 30, 2015
Record last verified: 2015-10